Stifel Nicolaus analyst Daniel Arias maintained a Buy rating on Codexis (CDXS – Research Report) today and set a price target of $5.00. The company’s shares closed yesterday at $3.14.
Stifel Nicolaus analyst Daniel Arias maintained a Buy rating on Codexis (CDXS – Research Report) today and set a price target of $5.00. The company’s shares closed yesterday at $3.14.
Codexis ( ($CDXS) ) has released its Q3 earnings. Here is a breakdown of the information Codexis presented to its investors. Codexis, Inc., a prominent name in enzymatic solutions for
Brendan Smith, an analyst from TD Cowen, maintained the Hold rating on Codexis (CDXS – Research Report). The associated price target is $3.00. Brendan Smith has given his Hold rating
Reports Q3 revenue $12.83M, consensus $11.48M. “Codexis (CDXS) had a strong third quarter, in which we surpassed product revenue goals, welcomed two new, highly experienced executives to our management team,
In a report released today, Matt Hewitt from Craig-Hallum reiterated a Buy rating on Codexis (CDXS – Research Report). The company’s shares closed yesterday at $3.18. According to TipRanks, Hewitt